{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:54:03Z","timestamp":1793580843146,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Annette Trust"},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020882","name":"University of Kent, GCDC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020882","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100016133","name":"James Tudor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Infection and blockage of indwelling urinary catheters is significant owing to its high incidence rate and severe medical consequences. Bacterial enzymes are employed as targets for small molecular intervention in human bacterial infections. Urease is a metalloenzyme known to play a crucial role in the pathogenesis and virulence of catheter-associated\n                    <jats:italic>Proteus mirabilis<\/jats:italic>\n                    infection. Targeting urease as a therapeutic candidate facilitates the disarming of bacterial virulence without affecting bacterial fitness, thereby limiting the selective pressure placed on the invading population and lowering the rate at which it will acquire resistance. We describe the design, synthesis, and in vitro evaluation of the small molecular enzyme inhibitor 2-mercaptoacetamide (2-MA), which can prevent encrustation and blockage of urinary catheters in a physiologically representative in vitro model of the catheterized urinary tract. 2-MA is a structural analogue of urea, showing promising competitive activity against urease. In silico docking experiments demonstrated 2-MA\u2019s competitive inhibition, whilst further quantum level modelling suggests two possible binding mechanisms.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-83257-2","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T06:07:44Z","timestamp":1613110064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections"],"prefix":"10.1038","volume":"11","author":[{"given":"Scarlet","family":"Milo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Heylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Glancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany L.","family":"Patenall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie J.","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naing T.","family":"Thet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Allinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisem","family":"Laabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Toby A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"83257_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2015.199","volume":"12","author":"HM Zowawi","year":"2015","unstructured":"Zowawi, H. M. et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat. Rev. Urol. 12, 570\u2013584 (2015).","journal-title":"Nat. Rev. Urol."},{"key":"83257_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jhin.2019.04.010","volume":"103","author":"DRM Smith","year":"2019","unstructured":"Smith, D. R. M. et al. Epidemiology and health-economic burden of urinary-catheter-associated infection in English NHS hospitals: A probabilistic modelling study. J. Hosp. Infect. 103, 44\u201354 (2019).","journal-title":"J. Hosp. Infect."},{"key":"83257_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/03091902.2015.1085600","volume":"39","author":"RCL Feneley","year":"2015","unstructured":"Feneley, R. C. L., Hopley, I. B. & Wells, P. N. T. Urinary catheters: History, current status, adverse events and research agenda. J. Med. Eng. Technol. 39, 459\u2013470 (2015).","journal-title":"J. Med. Eng. Technol."},{"key":"83257_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/ecosalplus.ESP-0009-2017","volume":"8","author":"CE Armbruster","year":"2018","unstructured":"Armbruster, C. E., Mobley, H. L. T. & Pearson, M. M. Pathogenesis of Proteus mirabilis infection. EcoSal Plus 8, 1\u201373 (2018).","journal-title":"EcoSal Plus"},{"key":"83257_CR5","first-page":"321","volume":"10","author":"TM Hooton","year":"2010","unstructured":"Hooton, T. M. et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 10, 321\u2013324 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"83257_CR6","first-page":"1032","volume":"3","author":"JN Schnauffer","year":"2015","unstructured":"Schnauffer, J. N. & Pearson, M. M. Proteus mirabilis and urinary tract infections. Microbiol. Spectr. 3, 1032\u20131057 (2015).","journal-title":"Microbiol. Spectr."},{"key":"83257_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0076-6879(99)10037-5","volume":"310","author":"DJ Stickler","year":"1999","unstructured":"Stickler, D. J., Morris, N. S. & Winters, C. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol. 310, 494\u2013501 (1999).","journal-title":"Methods Enzymol."},{"key":"83257_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s003450050159","volume":"17","author":"NS Morris","year":"1999","unstructured":"Morris, N. S., Stickler, D. J. & McLean, R. J. C. The development of bacterial biofilms on indwelling urethral catheters. World J. Urol. 17, 345\u2013350 (1999).","journal-title":"World J. Urol."},{"key":"83257_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/sc.2010.32","volume":"48","author":"DJ Stickler","year":"2010","unstructured":"Stickler, D. J. & Feneley, R. C. L. The encrustation and blockage of long-term indwelling bladder catheters: A way forward in prevention and control. Spinal Cord 48, 784\u2013790 (2010).","journal-title":"Spinal Cord"},{"key":"83257_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.tim.2016.11.015","volume":"25","author":"AN Norsworthy","year":"2017","unstructured":"Norsworthy, A. N. & Pearson, M. M. From catheter to kidney stone: the uropathogenic lifestyle of proteus mirabilis. Trends Microbiol. 25, 304\u2013315 (2017).","journal-title":"Trends Microbiol."},{"key":"83257_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0924-8579(00)00348-4","volume":"17","author":"S Choong","year":"2001","unstructured":"Choong, S., Wood, S., Fry, C. & Whitfield, H. Catheter associated urinary tract infection and encrustation. Int. J. Antimicrob. Agents 17, 305\u2013310 (2001).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"83257_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ajic.2017.05.009","volume":"45","author":"N Sabir","year":"2017","unstructured":"Sabir, N. et al. Bacterial biofilm-based catheter-associated urinary tract infections: Causative pathogens and antibiotic resistance. Am. J. Infect. Control 45, 1101\u20131105 (2017).","journal-title":"Am. J. Infect. Control"},{"key":"83257_CR13","first-page":"186","volume":"10","author":"CE Armbruster","year":"2013","unstructured":"Armbruster, C. E. & Mobley, H. L. T. Merging mythology and morphology: The multifaceted lifestyle of Proteus mirabilis. Nat. Rev. Microbiol. 10, 186\u2013194 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"83257_CR14","first-page":"496384","volume":"30","author":"A Zullo","year":"2020","unstructured":"Zullo, A. et al. Helicobacter pylori and plasma ammonia levels in cirrhotics: Role of urease inhibition by acetohydroxamic acid. Ital. J. Gastroenterol. Hepatol. 30, 496384 (2020).","journal-title":"Ital. J. Gastroenterol. Hepatol."},{"key":"83257_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jare.2018.05.010","volume":"13","author":"K Kappaun","year":"2018","unstructured":"Kappaun, K., Regina, A., Regina, C. & Ligabue-braun, R. Ureases: Historical aspects, catalytic, and non-catalytic properties\u2014A review. J. Adv. Res. 13, 3\u201317 (2018).","journal-title":"J. Adv. Res."},{"key":"83257_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0022-5347(17)49689-3","volume":"132","author":"JR Burns","year":"1984","unstructured":"Burns, J. R. & Gauthier, J. F. Prevention of urinary catheter incrustations by acetohydroxamic acid. J. Urol. 132, 455\u2013456 (1984).","journal-title":"J. Urol."},{"key":"83257_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000471707","volume":"20","author":"DP Griffith","year":"1991","unstructured":"Griffith, D. P. et al. Randomized, double-blind trial of Lithostat (Acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur. Urol. 20, 243\u2013247 (1991).","journal-title":"Eur. Urol."},{"key":"83257_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1056\/NEJM198409203111203","volume":"311","author":"JJ Williams","year":"1974","unstructured":"Williams, J. J., Rodman, J. S. & Peterson, C. M. A randomized double-blind study of acetohydroxamid acid in struvite nepholihiasis. N. Engl. J. Med. 311, 760\u2013764 (1974).","journal-title":"N. Engl. J. Med."},{"key":"83257_CR19","unstructured":"National Center for Biotechnology Information. PubChem Database. Acetohydroxamic acid, CID=1990, 1\u201319 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/1990#section=Pharmacology-and-Biochemistry (2020)."},{"key":"83257_CR20","unstructured":"Food and Drug Administration FDA. Approved Drug Products with Therapeutic Equivalence Evaluations. (Food and Drug Administration FDA, 2020)."},{"key":"83257_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.sbi.2018.08.010","volume":"53","author":"CM Kahler","year":"2018","unstructured":"Kahler, C. M., Sarkar-tyson, M., Kibble, E. A., Stubbs, K. A. & Vrielink, A. ScienceDirect Enzyme targets for drug design of new anti-virulence therapeutics. Curr. Opin. Struct. Biol. 53, 140\u2013150 (2018).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"83257_CR22","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.biochi.2011.06.030","volume":"93","author":"L Carson","year":"2011","unstructured":"Carson, L. et al. Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin). Biochimie 93, 1824\u20131827 (2011).","journal-title":"Biochimie"},{"key":"83257_CR23","first-page":"381","volume":"11","author":"LSB Upadhyay","year":"2012","unstructured":"Upadhyay, L. S. B. Urease inhibitors: A review. Indian J. Biotechnol. 11, 381\u2013388 (2012).","journal-title":"Indian J. Biotechnol."},{"key":"83257_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0040-6031(00)00451-2","volume":"354","author":"M Kot","year":"2000","unstructured":"Kot, M., Zaborska, W. & Juszkiewicz, A. Inhibition of jack bean urease by thiols. Calorimetric studies. Thermochim. Acta 354, 63\u201369 (2000).","journal-title":"Thermochim. Acta"},{"key":"83257_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2018.05.003","author":"YF Rego","year":"2018","unstructured":"Rego, Y. F. et al. A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2018.05.003 (2018).","journal-title":"J. Adv. Res."},{"key":"83257_CR26","first-page":"829","volume":"25","author":"L Mazzei","year":"2020","unstructured":"Mazzei, L. et al. Inhibition of urease, a Ni-enzyme: The reactivity of a key thiol with mono- and di-substituted catechols elucidated by kinetic, structural and theoretical studies. Angew. Chemie Int. Ed. 25, 829\u2013845 (2020).","journal-title":"Angew. Chemie Int. Ed."},{"key":"83257_CR27","unstructured":"Brenda. Information on EC 3.5.1.5\u2014Urease. 9\u201311. https:\/\/www.brenda-enzymes.org\/enzyme.php?ecno=3.5.1.5#ORGANISM (2020)."},{"key":"83257_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2174\/0929867023369853","volume":"9","author":"Z Amtul","year":"2002","unstructured":"Amtul, Z., Rahman, A., Siddiqui, R. A. & Choudhary, M. I. Chemistry and mechanism of urease inhibition. Curr. Med. Chem. 9, 1323\u20131348 (2002).","journal-title":"Curr. Med. Chem."},{"key":"83257_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"B Choi","year":"2017","unstructured":"Choi, B., Rempala, G. A. & Kim, J. K. Beyond the Michaelis\u2013Menten equation: Accurate and efficient estimation of enzyme kinetic parameters. Sci. Rep. 7, 1\u201311 (2017).","journal-title":"Sci. Rep."},{"key":"83257_CR30","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3109\/14756360902829766","volume":"24","author":"M Yoshino","year":"2009","unstructured":"Yoshino, M., Murakami, K., Yoshino, M. & Murakami, K. A graphical method for determining inhibition constants. J. Enzyme Inhib. Med. Chem. 24, 1288\u20131290 (2009).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"83257_CR31","volume-title":"Biochemistry","author":"J Berg","year":"2015","unstructured":"Berg, J., Tymoczko, J. & Stryer, L. Biochemistry (W H Freeman, New York, 2015)."},{"key":"83257_CR32","first-page":"S113","volume":"19","author":"S Kumar","year":"2010","unstructured":"Kumar, S. & Kayastha, A. M. Acetohydroxamic acid\u2014A competetitive inhibitor of urease from soybean (glycine max). Med. Chem. Res. 19, S113\u2013S114 (2010).","journal-title":"Med. Chem. Res."},{"key":"83257_CR33","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1099\/jmm.0.000342","volume":"65","author":"E Grela","year":"2016","unstructured":"Grela, E. et al. Whole-cell Proteus mirabilis urease inhibition by aminophosphinates for the control of struvite formation. J. Med. Microbiol. 65, 1123\u20131129 (2016).","journal-title":"J. Med. Microbiol."},{"key":"83257_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s007750050014","volume":"5","author":"S Benini","year":"2000","unstructured":"Benini, S. et al. The complex of Bacillus pasteurii urease with acetohydroxamate anion from X-ray data at 1.55\u00a0\u00c5 resolution. J. Biol. Inorg. Chem. 5, 110\u2013118 (2000).","journal-title":"J. Biol. Inorg. Chem."},{"key":"83257_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1008781006867","volume":"20","author":"H Gohlke","year":"2000","unstructured":"Gohlke, H., Hendlich, M. & Klebe, G. Predicting binding modes, binding affinities and \u2018hot spots\u2019 for protein-ligand complexes using a knowledge-based scoring function. Perspect. Drug Discov. Des. 20, 115\u2013144 (2000).","journal-title":"Perspect. Drug Discov. Des."},{"key":"83257_CR36","first-page":"15835","volume":"264","author":"MJ Todd","year":"1989","unstructured":"Todd, M. J. & Hausingers, R. P. Competitive inhibitors of Klebsiella aerogenes urease. Biochemistry 264, 15835\u201315842 (1989).","journal-title":"Biochemistry"},{"key":"83257_CR37","volume-title":"Noncovalent Bonds\u2014Molecular Cell Biology\u2014NCBI","author":"H Lodish","year":"2000","unstructured":"Lodish, H., Berk, A. & Zipursky, S. Noncovalent Bonds\u2014Molecular Cell Biology\u2014NCBI (W H Freeman, New York, 2000)."},{"key":"83257_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s007750050231","volume":"3","author":"S Benini","year":"1998","unstructured":"Benini, S., Rypniewski, W. R., Wilson, K. S., Ciurli, S. & Mangani, S. The complex of Bacillus pasteurii urease with \u03b2-mercaptoethanol from X- ray data at 1.65-\u00c5 resolution. J. Biol. Inorg. Chem. 3, 268\u2013273 (1998).","journal-title":"J. Biol. Inorg. Chem."},{"key":"83257_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jmr.2266","volume":"26","author":"E Yuriev","year":"2013","unstructured":"Yuriev, E. & Ramsland, P. A. Latest developments in molecular docking: 2010\u20132011 in review. J. Mol. Recognit. 26, 215\u2013239 (2013).","journal-title":"J. Mol. Recognit."},{"key":"83257_CR40","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/molecules23051038","volume":"23","author":"D Ram\u00edrez","year":"2018","unstructured":"Ram\u00edrez, D. & Caballero, J. Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural Data?. Molecules 23, 1038 (2018).","journal-title":"Molecules"},{"key":"83257_CR41","volume":"2010","author":"E Nordlander","year":"2010","unstructured":"Nordlander, E. & Carlsson, H. Computational modeling of the mechanism of urease. Bioinorg. Chem. Appl. 2010, 364891 (2010).","journal-title":"Bioinorg. Chem. Appl."},{"key":"83257_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jinorgbio.2016.11.016","volume":"166","author":"L Mazzei","year":"2017","unstructured":"Mazzei, L. et al. Inactivation of urease by catechol: Kinetics and structure. J. Inorg. Biochem. 166, 182\u2013189 (2017).","journal-title":"J. Inorg. Biochem."},{"key":"83257_CR43","unstructured":"Chemcraft\u2014Graphical software for visualization of quantum chemistry computations. https:\/\/www.chemcraftprog.com."},{"key":"83257_CR44","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/ja049618p","volume":"126","author":"S Benini","year":"2004","unstructured":"Benini, S., Rypniewski, W. R., Wilson, K. S., Mangani, S. & Ciurli, S. Molecular details of urease inhibition by boric acid: Insights into the catalytic mechanism. J. Am. Chem. Soc. 126, 3714\u20133715 (2004).","journal-title":"J. Am. Chem. Soc."},{"key":"83257_CR45","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s007750000204","volume":"6","author":"F Musiani","year":"2001","unstructured":"Musiani, F., Arnofi, E., Casadio, R. & Ciurli, S. Structure-based computational study of the catalytic and inhibition mechanisms of urease. J. Biol. Inorg. Chem. 6, 300\u2013314 (2001).","journal-title":"J. Biol. Inorg. Chem."},{"key":"83257_CR46","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1002\/anie.201903565","volume":"58","author":"L Mazzei","year":"2019","unstructured":"Mazzei, L., Cianci, M., Benini, S. & Ciurli, S. The structure of the elusive urease\u2014Urea complex unveils the mechanism of a paradigmatic nickel-dependent enzyme Angewandte. Angew. Chem. Int. Ed. 58, 7415\u20137419 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"83257_CR47","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1063\/1.464913","volume":"98","author":"AD Becke","year":"1993","unstructured":"Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 98, 5648 (1993).","journal-title":"J. Chem. Phys."},{"key":"83257_CR48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","volume":"37","author":"C Lee","year":"1988","unstructured":"Lee, C., Yang, W. & Parr, R. G. Development of the Colle\u2013Salvetti correlation-energy formula into a functional of the electron densitiy. Phys. Rev. B 37, 785\u2013789 (1988).","journal-title":"Phys. Rev. B"},{"key":"83257_CR49","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1139\/p80-159","volume":"58","author":"SH Vosko","year":"1980","unstructured":"Vosko, S. H., Wilk, L. & Nusair, M. Accurate spin-dependent electron liquid correlation energies for local spin density calculations: A critical analysis. Can. J. Phys. 58, 1200\u20131211 (1980).","journal-title":"Can. J. Phys."},{"key":"83257_CR50","doi-asserted-by":"publisher","first-page":"11623","DOI":"10.1021\/j100096a001","volume":"98","author":"PJ Stephens","year":"1994","unstructured":"Stephens, P. J., Devlin, F. J., Chabalowski, C. F. & Frisch, M. J. Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J. Phys. Chem. 98, 11623\u201311627 (1994).","journal-title":"J. Phys. Chem."},{"key":"83257_CR51","volume-title":"Methods of Electronic Structure Theory, Gaussian Basis Sets for Molecular Calculations, 1\u201327","author":"TJ Dunning","year":"1977","unstructured":"Dunning, T. J. & Schaefer, H. F. I. I. I. Methods of Electronic Structure Theory, Gaussian Basis Sets for Molecular Calculations, 1\u201327 (Plenum, New York, 1977)."},{"key":"83257_CR52","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1063\/1.1674902","volume":"54","author":"R Ditchfield","year":"1971","unstructured":"Ditchfield, R., Hehre, W. J. & Pople, J. A. Self-consistent molecular-orbital methods. IX. An extended Gaussian-type basis for molecular-orbital studies of organic molecules. J. Chem. Phys. 54, 724\u2013728 (1971).","journal-title":"J. Chem. Phys."},{"key":"83257_CR53","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1139\/m86-142","volume":"32","author":"RJC Mclean","year":"1986","unstructured":"Mclean, R. J. C., Cheng, K. J., Gould, W. D., Nickel, J. C. & Costerton, W. J. Histochemical and biochemical urease localization in the periplasm and outer membrane of two Proteus mirabilis strains. Can. J. Microbiol. 32, 772\u2013778 (1986).","journal-title":"Can. J. Microbiol."},{"key":"83257_CR54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/MR.59.3.451-480.1995","volume":"59","author":"HLT Mobley","year":"1995","unstructured":"Mobley, H. L. T., Island, M. D. & Hausinger, R. P. Molecular biology of microbial ureases. Microbiol. Rev. 59, 451\u2013480 (1995).","journal-title":"Microbiol. Rev."},{"key":"83257_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/092986732601190314143611","volume":"26","author":"AT Fiori-Duarte","year":"2019","unstructured":"Fiori-Duarte, A. T., Rodrigues, R. P., Kitagawa, R. R. & Kawano, D. F. Insights into the design of inhibitors of the urease enzyme\u2014A major target for the treatment of Helicobacter pylori infections. Curr. Med. Chem. 26, 1\u201315 (2019).","journal-title":"Curr. Med. Chem."},{"key":"83257_CR56","doi-asserted-by":"crossref","unstructured":"Nzakizwanayo, J., Pelling, H., Milo, S. & Jones, B. V. An In Vitro Bladder Model for Studying Catheter-Assoicated Urinary Tract Infection and Asssoicated Analysis of Biofilms. Springer Protocols, Methods in Molecular Biology. 139\u2013158 (2019).","DOI":"10.1007\/978-1-4939-9601-8_14"},{"key":"83257_CR57","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1128\/IAI.58.4.1120-1123.1990","volume":"58","author":"BD Jones","year":"1990","unstructured":"Jones, B. D., Lockatell, C. V., Johnson, D. E., Warren, J. W. & Mobley, H. L. T. Construction of a urease-negative mutant of Proteus mirabilis: Analysis of virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 58, 1120\u20131123 (1990).","journal-title":"Infect. Immun."},{"key":"83257_CR58","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1128\/IAI.61.7.2748-2754.1993","volume":"61","author":"DE Johnson","year":"1993","unstructured":"Johnson, D. E. et al. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect. Immun. 61, 2748\u20132754 (1993).","journal-title":"Infect. Immun."},{"key":"83257_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0300-483X(80)90110-9","volume":"16","author":"S Horvath","year":"1980","unstructured":"Horvath, S. Cytotoxicity of drugs and diverse chemical agents to cell cultures. Toxicology 16, 59\u201366 (1980).","journal-title":"Toxicology"},{"key":"83257_CR60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/jcp.47.2.188-b","volume":"47","author":"H Von Wulffen","year":"1994","unstructured":"Von Wulffen, H. & Marquardt, T. Cytotoxic activity of Helicobacter pylori enhanced by acetohydroxamic acid. J. Clin. Pathol. 47, 188\u2013189 (1994).","journal-title":"J. Clin. Pathol."},{"key":"83257_CR61","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/j.ddtec.2013.02.001","volume":"10","author":"CA Nicolaou","year":"2013","unstructured":"Nicolaou, C. A. & Brown, N. `1QMulti-objective optimization methods in drug design. Drug Discov. Today Technol. 10, e427\u2013e435 (2013).","journal-title":"Drug Discov. Today Technol."},{"key":"83257_CR62","doi-asserted-by":"crossref","unstructured":"Baringhaus, K. & Matter, H. Bioinformatics - From Genomes to Therapies: Efficient Strategies for Lead Optimization by Simultaneously Addressing Affinity, Selectivity and Pharmacokinetic Parameters, vol. 2, 705\u2013754 (2007).","DOI":"10.1002\/9783527619368.ch19"},{"key":"83257_CR63","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jlcr.3398","volume":"59","author":"B Latli","year":"2016","unstructured":"Latli, B., Eriksson, M., Hrapchak, M., Busacca, C. A. & Senanayake, C. H. A potentI\u03ba B kinase-\u03b2 inhibitor labeled with carbon-14 and deuterium. J. Label. Compd. Radiopharm. 59, 300\u2013304 (2016).","journal-title":"J. Label. Compd. Radiopharm."},{"key":"83257_CR64","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1021\/acsinfecdis.8b00345","volume":"5","author":"MR Bockman","year":"2019","unstructured":"Bockman, M. R. et al. Investigation of (S)-(\u2212)-acidomycin: A selective antimycobacterial natural product that inhibits biotin synthase. ACS Infect. Dis. 5, 598\u2013617 (2019).","journal-title":"ACS Infect. Dis."},{"key":"83257_CR65","first-page":"732","volume":"38","author":"AA Miles","year":"1938","unstructured":"Miles, A. A., Misra, S. S. & Irwin, J. O. The estimation of the bactericidal power of the blood. J. Hyg. (Lond.) 38, 732\u2013749 (1938).","journal-title":"J. Hyg. (Lond.)"},{"key":"83257_CR66","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.mimet.2013.09.018","volume":"95","author":"TO Okyay","year":"2013","unstructured":"Okyay, T. O. & Rodrigues, D. F. High throughput colorimetric assay for rapid urease activity quantification. J. Microbiol. Methods 95, 324\u2013326 (2013).","journal-title":"J. Microbiol. Methods"},{"key":"83257_CR67","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/00498251003698555","volume":"40","author":"HJ Burt","year":"2010","unstructured":"Burt, H. J., Galetin, A. & Houston, J. B. IC 50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4. Xenobiotica 40, 331\u2013343 (2010).","journal-title":"Xenobiotica"},{"key":"83257_CR68","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0969-2126(99)80026-4","volume":"7","author":"S Benini","year":"1999","unstructured":"Benini, S. et al. A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: Why urea hydrolysis costs two nickels. Structure 7, 205\u2013216 (1999).","journal-title":"Structure"},{"key":"83257_CR69","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1021\/ct800092p","volume":"4","author":"MJ Field","year":"2008","unstructured":"Field, M. J. The pDynamo program for molecular simulations using hybrid quantum chemical and molecular mechanical potentials. J. Chem. Theory Comput. 4, 1151\u20131161 (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"83257_CR70","unstructured":"Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Petersson, G. A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A. V., Bloino, J., Janesko, B. G., Gomperts, R., Mennucci, B., Hratch, W. C. Gaussian 16, Revision C.01. (2016)."},{"key":"83257_CR71","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00894-007-0233-4","volume":"13","author":"JJP Stewart","year":"2007","unstructured":"Stewart, J. J. P. Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. J. Mol. Model 13, 1173\u20131213 (2007).","journal-title":"J. Mol. Model"},{"key":"83257_CR72","unstructured":"Invitrogen. CyQUANT XTT Cell Viability Assay. Thermo Fisher Scientific Inc. https:\/\/www.thermofisher.com\/document-connect\/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FLSG%2Fmanuals%2FMAN0017857_CyQUANT_XTT_Cell_Viability_Assay_UG.pdf&title=VXNlciBHdWlkZTogQ3lRVUFOVCBYVFQgQ2VsbCBWaWFiaWxpdHkgQXNzY (2018)."},{"key":"83257_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-002-1_15","volume-title":"Screening of Fullerene Toxicity by Hemolysis Assay","author":"F Tramer","year":"2012","unstructured":"Tramer, F., Da Ros, T. & Passamonti, S. Screening of Fullerene Toxicity by Hemolysis Assay (Springer Science and Business Media, New York, 2012)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83257-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T22:45:13Z","timestamp":1670021113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83257-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83257"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83257-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"5 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3726"}}